Literature DB >> 12890806

Enhanced telomere shortening in transformed lymphoblasts from patients with X linked dyskeratosis.

L Montanaro1, P L Tazzari, M Derenzini.   

Abstract

AIM: Dyskeratosis congenita (DC) is characterised by the failure of those tissues that are rapidly dividing in the adult, particularly the skin, mucosae, and haemopoietic system. The X linked form of the disease is caused by mutations of the DKC1 gene, which encodes dyskerin, a protein that is necessary for the function of telomerase. Cultured DC lymphoblastoid cells are characterised by a reduced expansion of the cell population because of the progressive increase in apoptosis compared with the number of cell divisions. This report aimed to verify whether this is caused by a defect in telomerase function.
METHODS: Variations in telomere length over time were evaluated in two cultured lymphoblastoid cell lines derived from patients with X linked DC and control cells derived from a non-affected individual. In addition, the effect of inhibiting poly (ADP-ribose) polymerase (PARP), which is involved in the cellular response to excessive telomere shortening, was assessed. One DC cell line and the control cells were treated with the specific PARP inhibitor 1,5-dihydroxyquinoline (IQ).
RESULTS: In DC cells the increase in cell death was associated with progressive telomere shortening, and this was not seen in the control cells. Treatment with IQ delayed the increase of apoptosis in DC cells.
CONCLUSIONS: These observations indicate that the reduced expansion that characterises cultured cells obtained from patients with X linked DC is caused by premature telomere shortening.

Entities:  

Mesh:

Year:  2003        PMID: 12890806      PMCID: PMC1770038          DOI: 10.1136/jcp.56.8.583

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

1.  A telomerase component is defective in the human disease dyskeratosis congenita.

Authors:  J R Mitchell; E Wood; K Collins
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

Review 2.  Dyskeratosis congenita in all its forms.

Authors:  I Dokal
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

Review 3.  Repair of telomeric DNA prior to replicative senescence.

Authors:  P M Lansdorp
Journal:  Mech Ageing Dev       Date:  2000-09-01       Impact factor: 5.432

4.  Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death.

Authors:  B Herbert; A E Pitts; S I Baker; S E Hamilton; W E Wright; J W Shay; D R Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

5.  X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene.

Authors:  S W Knight; N S Heiss; T J Vulliamy; S Greschner; G Stavrides; G S Pai; G Lestringant; N Varma; P J Mason; I Dokal; A Poustka
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

6.  Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita.

Authors:  T J Vulliamy; S W Knight; P J Mason; I Dokal
Journal:  Blood Cells Mol Dis       Date:  2001 Mar-Apr       Impact factor: 3.039

7.  Dyskerin localizes to the nucleolus and its mislocalization is unlikely to play a role in the pathogenesis of dyskeratosis congenita.

Authors:  N S Heiss; A Girod; R Salowsky; S Wiemann; R Pepperkok; A Poustka
Journal:  Hum Mol Genet       Date:  1999-12       Impact factor: 6.150

8.  The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita.

Authors:  T Vulliamy; A Marrone; F Goldman; A Dearlove; M Bessler; P J Mason; I Dokal
Journal:  Nature       Date:  2001-09-27       Impact factor: 49.962

9.  Increased mortality rate and not impaired ribosomal biogenesis is responsible for proliferative defect in dyskeratosis congenita cell lines.

Authors:  Lorenzo Montanaro; Alessandra Chillà; Davide Trerè; Annalisa Pession; Marzia Govoni; Pier Luigi Tazzari; Massimo Derenzini
Journal:  J Invest Dermatol       Date:  2002-01       Impact factor: 8.551

10.  Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification.

Authors:  Davide Ruggero; Silvia Grisendi; Francesco Piazza; Eduardo Rego; Francesca Mari; Pulivarthi H Rao; Carlos Cordon-Cardo; Pier Paolo Pandolfi
Journal:  Science       Date:  2003-01-10       Impact factor: 47.728

View more
  4 in total

Review 1.  Telomere dysfunction in human bone marrow failure syndromes.

Authors:  Ludmila Shtessel; Shawn Ahmed
Journal:  Nucleus       Date:  2011 Jan-Feb       Impact factor: 4.197

Review 2.  Nucleolus, ribosomes, and cancer.

Authors:  Lorenzo Montanaro; Davide Treré; Massimo Derenzini
Journal:  Am J Pathol       Date:  2008-06-26       Impact factor: 4.307

Review 3.  Molecular basis of telomere dysfunction in human genetic diseases.

Authors:  Grzegorz Sarek; Paulina Marzec; Pol Margalef; Simon J Boulton
Journal:  Nat Struct Mol Biol       Date:  2015-11       Impact factor: 15.369

Review 4.  New Insights into Connection of Nucleolar Functions and Cancer.

Authors:  Moslem Bahadori
Journal:  Tanaffos       Date:  2019-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.